Found 933 matching trials
Delayed Tolerance Through Mixed Chimerism PHASE1 This study will examine the safety and effectiveness of a bone marrow trans...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma PHASE2 This study is being done to find out how effective a new treatment strategy...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma PHASE2 There is no standard treatment for chondrosarcoma. Some small sample of stu...
Show More Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases PHASE2 Approximately 40% of colorectal cancer patients will develop colorectal liv...
Show More Location
Severance Hospital, Yonsei University Health System
Learn More & Join Trial
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System PHASE2 To seek the efficacy signals of trastuzumab in combination with chemotherap...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 PHASE2 Background:
Colorectal cancer is a common cancer in the Unites States (U.S...
Show More Location
Lombardi Comprehensive Cancer Center
Learn More & Join Trial
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma PHASE2 Background:
The disease follicular lymphoma (FL) develops when the body ma...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. PHASE2 This is a multicenter, two-arm, exploratory clinical study designed to eval...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer NA This is a prospective, randomized study to compare the efficacy of TP (Taxa...
Show More Learn More & Join Trial
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer PHASE2 This research study is studying an investigational drug as a possible treat...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial